Hypomyelinating leukodystrophy: From molecular mechanisms to clinical advances
Brain and Development · 2025
DOI: 10.1016/j.braindev.2025.104426 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Development, 2025. Verfasst von Hitoshi Osaka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Pediatrics, Jichi Medical School, Japan. Electronic address: hosaka@jichi.ac.jp. Hauptthemen laut MEDLINE: Pelizaeus-Merzbacher Disease, Hereditary Central Nervous System Demyelinating Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dept. of Pediatrics, Jichi Medical School, Japan. Electronic address: hosaka@jichi.ac.jp.
- Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Osaka, H., & Inoue, K. (2025). Hypomyelinating leukodystrophy: From molecular mechanisms to clinical advances. Brain and Development. https://doi.org/10.1016/j.braindev.2025.104426
Vancouver
Osaka H, Inoue K. Hypomyelinating leukodystrophy: From molecular mechanisms to clinical advances. Brain and Development. 2025. doi:10.1016/j.braindev.2025.104426
BibTeX
@article{Osaka2025,
author = {Osaka, Hitoshi and Inoue, Ken},
title = {Hypomyelinating leukodystrophy: From molecular mechanisms to clinical advances},
journal = {Brain and Development},
year = {2025},
doi = {10.1016/j.braindev.2025.104426}
}
EUVIMED